US – FDA Issues New Policy on Remote Monitoring Devices Used to Support Patient Monitoring During COVID-19
Published in COVID-19, Patient Monitoring and United States Food and Drug Administration - US FDA
More from COVID-19More posts in COVID-19 »
- EU – Availability and capacity of notified bodies to carry out conformity assessments for COVID-19 related medical devices and in vitro diagnostic medical devices
- EU – Guidance on temporary extraordinary measures related to medical device Notified Body audits during COVID-19 quarantine orders and travel restrictions
- WHO – Critical items for clinical management of COVID-19
- EU – Guidance on medical devices, active implantable medical devices and in vitro diagnostic medical devices in the COVID-19 context
- Free emergency regulatory service – Medical device registration in Brazil
More from United States Food and Drug Administration - US FDAMore posts in United States Food and Drug Administration - US FDA »
- EU – Team-NB Position Paper on Documentation Requirements for Drug Device Combination Products Falling in the Scope of Article 117 of MDR 2017/745.
- US – FDA Issues Immediately in Effect Guidance on Ventilators During COVID-19
- US – Ventilator Supply Mitigation Strategies – Letter to Health Care Providers
- US – Update on the Ethylene Oxide Sterilization Master File Pilot Program
- US – FDA Engagement to Mitigate Potential Shortage of Personal Protective Equipment (PPE)
Be First to Comment